Myung In Pharmaceutical LTD. (KRX:317450)
South Korea flag South Korea · Delayed Price · Currency is KRW
56,900
+600 (1.07%)
At close: Apr 8, 2026

KRX:317450 Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
830,7401,005,940----
Enterprise Value
322,434532,289----
Last Close Price
56900.0068900.00----
PE Ratio
8.4712.35----
PS Ratio
2.893.50----
PB Ratio
1.051.27----
P/TBV Ratio
1.051.27----
P/FCF Ratio
16.1219.52----
P/OCF Ratio
10.1912.33----
EV/Sales Ratio
1.121.85----
EV/EBITDA Ratio
3.125.15----
EV/EBIT Ratio
3.495.76----
EV/FCF Ratio
6.2610.33----
Debt / Equity Ratio
0.000.000.010.010.010.02
Debt / EBITDA Ratio
0.010.010.030.040.060.07
Debt / FCF Ratio
0.030.030.040.050.090.09
Net Debt / Equity Ratio
-0.64-0.64-0.48-0.39-0.32-0.31
Net Debt / EBITDA Ratio
-4.91-4.91-2.45-1.93-1.58-1.34
Net Debt / FCF Ratio
-9.87-9.87-3.54-2.57-2.39-1.82
Asset Turnover
0.400.400.490.490.500.52
Inventory Turnover
1.821.821.731.701.741.56
Quick Ratio
12.5212.527.286.375.764.52
Current Ratio
13.9313.938.657.857.155.71
Return on Equity (ROE)
12.28%12.28%13.68%16.63%14.36%16.91%
Return on Assets (ROA)
8.12%8.12%10.51%10.52%10.53%11.41%
Return on Invested Capital (ROIC)
25.26%26.33%25.70%23.54%19.48%21.07%
Return on Capital Employed (ROCE)
11.60%11.60%17.30%17.30%17.40%19.00%
Earnings Yield
9.80%8.09%----
FCF Yield
6.20%5.12%----
Payout Ratio
13.75%13.75%8.15%30.06%19.50%23.43%
Buyback Yield / Dilution
-8.23%-8.23%-0.01%---
Total Shareholder Return
-5.39%-8.23%-0.01%---
Source: S&P Global Market Intelligence. Standard template. Financial Sources.